PROVIDER PROFILE · NPI 1568441665
Daniel SkubickM.D.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
578
Unique beneficiaries
—
Total services
18,461
Distinct HCPCS
15
Medicare payment
$204K
Peer benchmark
Total Medicare services vs. 850 Neurology providers in PA — top quintile (cohort median 399).
PRESCRIBING · PART D · 2024
Total Rx claims
1,269
Beneficiaries
—
Total drug cost
$509K
Distinct drugs
35
Brand share
40.2%
Top prescribed drugs
Morphine Sulfate126 claims
Hydrocodone/Acetaminophen121 claims
Oxycodone Hcl/Acetaminophen105 claims
Oxycodone Hcl79 claims
Cyclobenzaprine Hcl76 claims
QUALITY · MIPS · 2024
Final MIPS score
81.4
Quality
78.0
Cost
65.9
Improvement activities
40.0
Promoting interop.
93.0
Payment adjustment
0.27%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (4)
REFERRAL NETWORK
Where Daniel Skubick's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Quest Diagnostics Clinical Laboratories Inc Clinical Laboratory · Norristown, PA | 46 | 106 |
| LANSDALE HOSPITAL CORPORATION | 14 | 32 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE